Sermorelin vs Tesamorelin
The original growth hormone booster that works with your body's natural rhythm—it tells your pituitary gland to release more GH instead of replacing it, keeping your hormonal feedback system healthy and balanced.
The only FDA-approved peptide specifically designed to melt away stubborn belly fat by telling your brain to release more growth hormone naturally—working with your body's own systems rather than replacing them [6].
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Quick comparison
Dose range
Sermorelin
200–300 mcg
Tesamorelin
2–2 mg
Frequency
Sermorelin
Once daily
Tesamorelin
Once daily
Administration
Sermorelin
Subcutaneous injection
Tesamorelin
Subcutaneous injection
Cycle length
Sermorelin
12+ weeks
Tesamorelin
12+ weeks
Onset speed
Sermorelin
Moderate (1-2 weeks)
Tesamorelin
Moderate (1-2 weeks)
Evidence level
Sermorelin
Moderate human trials (Phase 1-2)
Tesamorelin
Strong human trials (Phase 3 or FDA approved)
Benefit ratings
GH Optimization
Sleep Quality
Body Composition
Visceral Fat Reduction
Metabolic Health
Natural GH Boost
Compound specifications
Sermorelin
Molecular formula
C149H246N44O42S
Molecular weight
3357.9 g/mol
Half-life
10-20 minutes
Bioavailability
High when injected subcutaneously; degraded orally
CAS number
86168-78-7
Tesamorelin
Molecular formula
C221H366N72O67S
Molecular weight
5135.86 g/mol
Half-life
26-38 minutes
Bioavailability
~100% (subcutaneous injection)
CAS number
218949-48-5
Dosing compared
Sermorelin
Subcutaneous
100-200 mcg
Once daily at bedtime · 4-6 weeks
Community-practice dose, not one studied in adults. The adult trials used 0.5–1 mg twice daily [1] or 2 mg nightly [3]; the pediatric label dose was 30 mcg/kg at bedtime [6].
200-300 mcg
Once daily at bedtime · 3-6 months
Community-practice dose. Twice-daily 1 mg (not 200–300 mcg) is the dose that restored GH and IGF-1 in older men [1].
Tesamorelin
Subcutaneous
2 mg (1.4 mg with Egrifta SV/WR F8 formulation)
Once daily · 26 weeks, continued long-term for sustained effect
FDA-approved dose for HIV-associated lipodystrophy; full dose from day one with no titration [6]. Pivotal phase 3 trials used 2 mg daily [1].
Best suited for
Sermorelin
Adults Experiencing Age-Related GH Decline
After age 30, your growth hormone production naturally declines about 14% per decade. [9] Sermorelin helps restore more youthful GH levels by stimulating your own pituitary rather than shutting it down with external hormones. [1][13] It's like giving your hormone system a gentle nudge back to where it used to be.
Body Composition Optimizers
Evidence for body composition is limited. A GHRH analog increased lean mass in older men but not women, with no change in fat [2]; 6 weeks of nightly sermorelin changed neither muscle nor fat [3]. Larger, longer studies are lacking. [8]
Sleep Quality Seekers
Growth hormone is intimately tied to deep, restorative sleep. [10] By enhancing your natural nighttime GH pulses, sermorelin often improves sleep quality as a welcome side effect. [8] Many users report falling asleep faster and waking more refreshed.
Those Wanting a Safer Alternative to HGH
Direct HGH injections bypass your body's feedback system and can suppress your own production. [13] Sermorelin works differently—it asks your pituitary to make more GH naturally. This preserves your body's regulatory mechanisms and carries a lower risk of side effects. [8]
Tesamorelin
People with Stubborn Visceral Fat
If you carry your weight around your midsection—the deep belly fat that wraps around your organs—tesamorelin is specifically designed for you. Unlike weight loss drugs, it targets visceral fat while preserving the normal subcutaneous fat that's healthy to have [5].
HIV Patients with Lipodystrophy
Tesamorelin is FDA-approved specifically for HIV-associated lipodystrophy—the abnormal fat accumulation in the belly that antiretroviral medications can cause [6]. It's the only treatment proven to help this condition, reducing both the physical and psychological burden [1][5].
Those Concerned About Metabolic Health
Visceral fat isn't just cosmetic—it's metabolically dangerous, linked to heart disease, diabetes, and inflammation [10][12]. By reducing visceral fat, tesamorelin also improves triglycerides, cholesterol ratios, and may help protect your liver from fatty liver disease [1][2][4].
Adults Wanting Natural GH Stimulation
Unlike synthetic growth hormone injections, tesamorelin works WITH your body's natural systems. It tells your pituitary to release more of YOUR OWN growth hormone, maintaining normal feedback loops and reducing the risks associated with supraphysiological GH levels [10].
Side effects
Sermorelin
Common
- Injection site reactions
- Facial flushing
Uncommon
- Headache
- Sleepiness or drowsiness
- Nausea
- Hyperactivity or difficulty sleeping
Serious
- Severe allergic reaction
Tesamorelin
Common
- Injection site reactions
- Joint pain (arthralgia)
- Muscle pain (myalgia)
- Peripheral edema
Uncommon
- Carpal tunnel symptoms
- Elevated blood glucose
Serious
- Severe allergic reaction
- Worsening diabetes
Safety & evidence
Sermorelin
Evidence level
Moderate human trials (Phase 1-2)
FDA status
Not currently FDA approved. GEREF (sermorelin) was approved in 1997 for growth failure in children with GH deficiency; EMD Serono discontinued it in 2008 and FDA withdrew the approvals at its request in 2009, not for safety or effectiveness reasons. Sermorelin sold today is compounded, not an FDA-approved product.
Safety overview
Sermorelin works through the body's own GH feedback, which limits excessive hormone levels. [8][13] On the GEREF label, the most common reaction to repeated injections was a local reaction (about 1 in 6 patients); headache, flushing, dizziness, hyperactivity and somnolence each occurred in under 1%, and many patients developed anti-GRF antibodies. [16] Facial flushing and injection-site pain were the most commonly reported events in the pediatric studies. [6] GEREF was FDA-approved in 1997 for children with GH deficiency. [7]
Contraindications
- Active cancer or history of cancer
- Pregnancy or breastfeeding
- Known allergy to sermorelin or any peptide components
- Pituitary tumors or other pituitary disorders
- Diabetic retinopathy
Tesamorelin
Evidence level
Strong human trials (Phase 3 or FDA approved)
FDA status
FDA approved for other use
Safety overview
Tesamorelin has a strong safety profile backed by FDA approval and multiple large Phase 3 clinical trials involving over 800 patients [1][6]. The most common issues are injection site reactions and the typical side effects of elevated growth hormone (joint pain, fluid retention) [6]. Glucose metabolism should be monitored as some patients experience increased blood sugar [6]. Long-term cardiovascular safety data is still being collected, which is why the FDA recommends reassessing treatment if visceral fat doesn't reduce [6].
Contraindications
- Active malignancy [6] or history of cancer (pituitary tumors especially)
- Known hypersensitivity to tesamorelin or mannitol [6]
- Pregnancy [6]
- Disruption of the hypothalamic-pituitary axis from conditions like hypophysectomy or pituitary tumor surgery [6]
Which is right for you?
Choose Sermorelin if...
- Anti-aging and vitality
- Body composition improvement
- Sleep quality enhancement
- Exercise recovery
Choose Tesamorelin if...
- Reducing visceral abdominal fat
- Improving metabolic health markers
- Supporting natural growth hormone production
- Addressing HIV-associated lipodystrophy